The new Chancellor of the Exchequer gave her first Mansion House speech on 14 November 2024. The speech announced a range of measures which aim to: ...

Global law firm Clifford Chance has achieved a major victory for its client, elevator and escalator industry leader KONE, in defeating a EUR 12 million follow-on damages claim brought by the EU ...

Global law firm Clifford Chance has advised Standard Chartered on an innovative debt conversion transaction for the Commonwealth of The Bahamas. The transaction involved Standard Chartered providing a ...

Clifford Chance advised lux-Airport on the development financing of the landmark Skypark Business Center property in one of the largest single property financing transactions in Luxembourg to date ...

Clifford Chance advises the EIB on its issuance of digital bonds on HSBC Orion as part of the Eurosystem Exploratory Work Global law firm Clifford Chance has advised the European Investment Bank (EIB) ...

It is a fundamental principle of insurance law that policies provide cover for loss caused by the insured peril, and exclude losses caused by an excluded cause. In recent times the English Courts have ...

In this issue, dedicated to the ICA's decisions for the month of October 2024: Unfair commercial practices: the ICA imposes a €2 million fine on Star Italia S.p.A. Unfair commercial practices: the ICA ...

In the context of heightened geopolitical tensions and persisting challenges affecting the EU economy, the European Commission ("Commission") published on 17 October 2024 its fourth annual report on ...

The Markets in Crypto-Assets Regulation (MiCA) delivers a new EU-wide regulatory framework for issuing, intermediating and dealing in crypto-assets. Under MiCA, Crypto-asset service providers (CASPs) ...

On 1 May 2024, Federal Law Decree 51/2023 on Financial Restructuring and Bankruptcy (the "2024 Bankruptcy Law") came into force and replaced the previous 2016 bankruptcy law (the "2016 Bankruptcy Law" ...

Global law firm Clifford Chance is advising Charme Capital Partners, a pan-European private equity firm, on the envisaged acquisition of Centogene GmbH, a rare diseases company focused on transforming ...